Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect
出版年份 2018 全文链接
标题
Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect
作者
关键词
Cancer, Immunotherapy, Molecular imaging, Immune checkpoint target
出版物
EUROPEAN RADIOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-11-30
DOI
10.1007/s00330-018-5814-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments
- (2018) Yang Du et al. CANCER LETTERS
- In Vivo Imaging of the Programmed Death Ligand 1 by18F PET
- (2017) Dinko E. González Trotter et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and Biologic Evaluation of a Novel18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression
- (2017) David J. Donnelly et al. JOURNAL OF NUCLEAR MEDICINE
- Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-64Cu/IRDye800CW Allows Improved Breast Tumor Targeted Imaging and Therapy
- (2017) Yang Du et al. MOLECULAR PHARMACEUTICS
- ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer
- (2017) Emily B. Ehlerding et al. MOLECULAR PHARMACEUTICS
- PD-L1 Detection in Tumors Using [64Cu]Atezolizumab with PET
- (2016) Wojciech G. Lesniak et al. BIOCONJUGATE CHEMISTRY
- Checkpoint Inhibitors and Their Application in Breast Cancer
- (2016) Davide Bedognetti et al. Breast Care
- Molecular Imaging of Immunotherapy Targets in Cancer
- (2016) E. B. Ehlerding et al. JOURNAL OF NUCLEAR MEDICINE
- Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging
- (2016) Aaron T. Mayer et al. JOURNAL OF NUCLEAR MEDICINE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
- (2016) Samit Chatterjee et al. Oncotarget
- High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers
- (2016) Michael Hettich et al. Theranostics
- Novel Radiotracer for ImmunoPET Imaging of PD-1 Checkpoint Expression on Tumor Infiltrating Lymphocytes
- (2015) Arutselvan Natarajan et al. BIOCONJUGATE CHEMISTRY
- Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies
- (2015) S. Heskamp et al. CANCER RESEARCH
- Cancer Immunotherapy: A Future Paradigm Shift in the Treatment of Non-Small Cell Lung Cancer
- (2015) V. K. Anagnostou et al. CLINICAL CANCER RESEARCH
- Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma
- (2015) Yuki Katsuya et al. LUNG CANCER
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging
- (2015) Roy L. Maute et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
- (2015) Kim C. Ohaegbulam et al. TRENDS IN MOLECULAR MEDICINE
- T cell-NF-κB activation is required for tumor control in vivo
- (2015) Sarah E Barnes et al. Journal for ImmunoTherapy of Cancer
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- 64Cu-DOTA-Anti-CTLA-4 mAb Enabled PET Visualization of CTLA-4 on the T-Cell Infiltrating Tumor Tissues
- (2014) Kei Higashikawa et al. PLoS One
- Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients
- (2014) Floor C. J. van de Watering et al. Biomed Research International
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
- (2013) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
- (2013) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- New checkpoint inhibitors ride the immunotherapy tsunami
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
- (2012) Michelle L. James et al. PHYSIOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now